Clinical Exploration of Involved-field Radiotherapy-TNT Combined With PD-1 Inhibitor for pMMR Locally Advanced Rectal Cancer: a Prospective, Single-center, Open-label, Randomized Controlled Trial (Neo-Field I)
Latest Information Update: 17 Jul 2025
At a glance
- Drugs Camrelizumab (Primary)
- Indications Rectal cancer
- Focus Therapeutic Use
Most Recent Events
- 17 Jul 2025 New trial record